Literature DB >> 21343873

Morphologic differences, according to etiology, in pigment epithelial detachments by means of en face optical coherence tomography.

Bruno Lumbroso1, Maria Cristina Savastano, Marco Rispoli, Angelo Balestrazzi, Alfonso Savastano, Emilio Balestrazzi.   

Abstract

PURPOSE: To assess morphologic differences in pigment epithelial detachment (PED) with en face optical coherence tomography in central serous chorioretinopathy (CSC) and age-related macular degeneration (AMD).
METHODS: We recruited 30 eyes of 22 patients with PED. Nine eyes had a clinical diagnosis of CSC and 21 had AMD. All patients were assessed with en face optical coherence tomography. Morphologic PED aspects were estimated on C-scans and classified according to shape, inner silhouette, content, wall aspects, wall thickness, and size.
RESULTS: Pigment epithelial detachment shape was predominantly circular (88.8%) in CSC and irregular or with multilobular features in AMD (76.2%). The PED inner silhouette had a smooth aspect (88.9%) in CSC and a slightly granular aspect or granular profile in AMD (100%). Clear PED content was the most characteristic feature of CSC (88.9%) but not of AMD. In CSC, PED morphologic wall aspect was uniform or slightly irregular (100%), while in AMD, it was slightly irregular (52.4%) or irregular (47.6%). Pigment epithelial detachment wall thickness and dimensions were larger in AMD than in CSC. Statistically significant differences were observed between CSC and AMD concerning PED inner silhouette, contents, wall aspects, and wall thickness measurements.
CONCLUSION: En face optical coherence tomography scanning is a valuable tool for showing important morphologic differences between CSC and AMD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21343873     DOI: 10.1097/IAE.0b013e3181eef3eb

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  [Spectral domain OCT in central serous chorioretinopathy: description of retinal changes].

Authors:  V Valet; C P Lohmann; M Maier
Journal:  Ophthalmologe       Date:  2012-09       Impact factor: 1.059

2.  ASSESSING PHOTORECEPTOR STRUCTURE ASSOCIATED WITH ELLIPSOID ZONE DISRUPTIONS VISUALIZED WITH OPTICAL COHERENCE TOMOGRAPHY.

Authors:  Drew Scoles; John A Flatter; Robert F Cooper; Christopher S Langlo; Scott Robison; Maureen Neitz; David V Weinberg; Mark E Pennesi; Dennis P Han; Alfredo Dubra; Joseph Carroll
Journal:  Retina       Date:  2016-01       Impact factor: 4.256

3.  Blue-light fundus autofluorescence imaging of pigment epithelial detachments.

Authors:  Almut Bindewald-Wittich; Joanna Dolar-Szczasny; Sandrine H Kuenzel; Leon von der Emde; Maximilian Pfau; Robert Rejdak; Steffen Schmitz-Valckenberg; Thomas Ach; Jens Dreyhaupt; Frank G Holz
Journal:  Eye (Lond)       Date:  2022-05-17       Impact factor: 3.775

Review 4.  En-face optical coherence tomography in the diagnosis and management of age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Tiffany Lau; Ian Y Wong; Lawrence Iu; Jay Chhablani; Tao Yong; Koizumi Hideki; Jacky Lee; Raymond Wong
Journal:  Indian J Ophthalmol       Date:  2015-05       Impact factor: 1.848

5.  Isolated multiple pigment epithelial detachments with unknown cause.

Authors:  Arzu Seyhan Karatepe Hashas; Altan Göktas; Mustafa Atas
Journal:  Case Rep Ophthalmol Med       Date:  2014-02-04

6.  Seven-year evaluation of idiopathic multiple retinal pigment epithelium detachments.

Authors:  Pawel Krasnicki; Diana Dmuchowska; Ewa Zukowska; Zofia Mariak
Journal:  GMS Ophthalmol Cases       Date:  2016-10-05

7.  Factors related to the location of pigment epithelial detachment in central serous chorioretinopathy.

Authors:  Young Ho Kim; Edward Kang; Jaeryung Oh
Journal:  Sci Rep       Date:  2022-03-16       Impact factor: 4.379

8.  THE INCIDENCE OF NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.

Authors:  M Cristina Savastano; Marco Rispoli; Bruno Lumbroso
Journal:  Retina       Date:  2021-02-01       Impact factor: 3.975

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.